These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 34255743)

  • 1. WNT6/ACC2-induced storage of triacylglycerols in macrophages is exploited by Mycobacterium tuberculosis.
    Brandenburg J; Marwitz S; Tazoll SC; Waldow F; Kalsdorf B; Vierbuchen T; Scholzen T; Gross A; Goldenbaum S; Hölscher A; Hein M; Linnemann L; Reimann M; Kispert A; Leitges M; Rupp J; Lange C; Niemann S; Behrends J; Goldmann T; Heine H; Schaible UE; Hölscher C; Schwudke D; Reiling N
    J Clin Invest; 2021 Aug; 131(16):. PubMed ID: 34255743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt6 is expressed in granulomatous lesions of Mycobacterium tuberculosis-infected mice and is involved in macrophage differentiation and proliferation.
    Schaale K; Brandenburg J; Kispert A; Leitges M; Ehlers S; Reiling N
    J Immunol; 2013 Nov; 191(10):5182-95. PubMed ID: 24123681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of autophagy through CLEC4E in combination with TLR4: an innovative strategy to restrict the survival of
    Pahari S; Negi S; Aqdas M; Arnett E; Schlesinger LS; Agrewala JN
    Autophagy; 2020 Jun; 16(6):1021-1043. PubMed ID: 31462144
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Shim D; Kim H; Shin SJ
    Front Immunol; 2020; 11():910. PubMed ID: 32477367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterium tuberculosis uses host triacylglycerol to accumulate lipid droplets and acquires a dormancy-like phenotype in lipid-loaded macrophages.
    Daniel J; Maamar H; Deb C; Sirakova TD; Kolattukudy PE
    PLoS Pathog; 2011 Jun; 7(6):e1002093. PubMed ID: 21731490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Berberine as an Adjunct to TB Treatment.
    Ozturk M; Chia JE; Hazra R; Saqib M; Maine RA; Guler R; Suzuki H; Mishra BB; Brombacher F; Parihar SP
    Front Immunol; 2021; 12():656419. PubMed ID: 34745081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pasakbumin A controls the growth of Mycobacterium tuberculosis by enhancing the autophagy and production of antibacterial mediators in mouse macrophages.
    Lee HJ; Ko HJ; Kim SH; Jung YJ
    PLoS One; 2019; 14(3):e0199799. PubMed ID: 30865638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungs.
    Subbian S; Tsenova L; O'Brien P; Yang G; Koo MS; Peixoto B; Fallows D; Dartois V; Muller G; Kaplan G
    PLoS Pathog; 2011 Sep; 7(9):e1002262. PubMed ID: 21949656
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Stüve P; Minarrieta L; Erdmann H; Arnold-Schrauf C; Swallow M; Guderian M; Krull F; Hölscher A; Ghorbani P; Behrends J; Abraham WR; Hölscher C; Sparwasser TD; Berod L
    Front Immunol; 2018; 9():495. PubMed ID: 29675017
    [No Abstract]   [Full Text] [Related]  

  • 10. B and T lymphocyte attenuator regulates autophagy in mycobacterial infection via the AKT/mTOR signal pathway.
    Liu J; Ming S; Song W; Meng X; Xiao Q; Wu M; Wu Y; Xie H; Zhou J; Zhong H; Huang X
    Int Immunopharmacol; 2021 Feb; 91():107215. PubMed ID: 33348294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage targeted polymeric curcumin nanoparticles limit intracellular survival of
    Gupta PK; Jahagirdar P; Tripathi D; Devarajan PV; Kulkarni S
    Front Immunol; 2023; 14():1233630. PubMed ID: 37583694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A human xenobiotic nuclear receptor contributes to nonresponsiveness of
    Bhagyaraj E; Tiwari D; Ahuja N; Nanduri R; Saini A; Kalra R; Kumar S; Janmeja AK; Gupta P
    J Biol Chem; 2018 Mar; 293(10):3747-3757. PubMed ID: 29358328
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjunctive Host-Directed Therapy With Statins Improves Tuberculosis-Related Outcomes in Mice.
    Dutta NK; Bruiners N; Zimmerman MD; Tan S; Dartois V; Gennaro ML; Karakousis PC
    J Infect Dis; 2020 Mar; 221(7):1079-1087. PubMed ID: 31605489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrogen sulfide dysregulates the immune response by suppressing central carbon metabolism to promote tuberculosis.
    Rahman MA; Cumming BM; Addicott KW; Pacl HT; Russell SL; Nargan K; Naidoo T; Ramdial PK; Adamson JH; Wang R; Steyn AJC
    Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6663-6674. PubMed ID: 32139610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphodiesterase 4 inhibition reduces innate immunity and improves isoniazid clearance of Mycobacterium tuberculosis in the lungs of infected mice.
    Koo MS; Manca C; Yang G; O'Brien P; Sung N; Tsenova L; Subbian S; Fallows D; Muller G; Ehrt S; Kaplan G
    PLoS One; 2011 Feb; 6(2):e17091. PubMed ID: 21364878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage-targeted versus free calcitriol as host-directed adjunct therapy against Mycobacterium tuberculosis infection in mice is bacteriostatic and mitigates tissue pathology.
    Reddy DVS; Sofi HS; Roy T; Verma S; Washimkar KR; Raman SK; Singh S; Azmi L; Ray L; Singh J; Mugale MN; Singh AK; Misra A
    Tuberculosis (Edinb); 2024 Sep; 148():102536. PubMed ID: 38976934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential effect of ezetimibe against Mycobacterium tuberculosis infection in type II diabetes.
    Tsai IF; Kuo CP; Lin AB; Chien MN; Ho HT; Wei TY; Wu CL; Lu YT
    Respirology; 2017 Apr; 22(3):559-566. PubMed ID: 27879023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Inhibition of Host Histone Deacetylases (HDACs) Enhances
    Moreira JD; Koch BEV; van Veen S; Walburg KV; Vrieling F; Mara Pinto Dabés Guimarães T; Meijer AH; Spaink HP; Ottenhoff THM; Haks MC; Heemskerk MT
    Front Immunol; 2020; 11():36. PubMed ID: 32117228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic Treatment Shapes the Antigenic Environment During Chronic TB Infection, Offering Novel Targets for Therapeutic Vaccination.
    Chuang YM; Dutta NK; Gordy JT; Campodónico VL; Pinn ML; Markham RB; Hung CF; Karakousis PC
    Front Immunol; 2020; 11():680. PubMed ID: 32411131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.